LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

LLY

906.48

-1.97%↓

UNH

577.95

-2%↓

NVO

131.97

-3.67%↓

JNJ

167.31

+0.18%↑

ABBV

193.29

-1.3%↓

Search

Apellis Pharmaceuticals Inc

Cerrado

Sector Salud

35.51 -2.26

Resumen

Variación precio

24h

Actual

Mínimo

35.15

Máximo

36.87

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 meses

+94.44 upside

Dividendos

By Dow Jones

Próximas Ganancias

30 oct 2024

Noticias sobre sentimiento de mercado

By Acuity

43%

57%

104 / 366 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Apellis Pharmaceuticals Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

17 sept 2024, 23:10 UTC

Principales Noticias

Bank of Canada Welcomes 2% Inflation, Pivoting Focus to Growth

17 sept 2024, 16:37 UTC

Ganancias

Correction to Walmart Headlines on Aug. 15

17 sept 2024, 16:21 UTC

Adquisiciones, fusiones, absorciones

Generali Agrees to Sale of Turkish Business

17 sept 2024, 16:03 UTC

Ganancias

Correction to Estee Lauder Headline on Aug. 19

17 sept 2024, 21:45 UTC

Principales Noticias

UAW Clashes With Jeep Maker Stellantis Over Promised Factory Work -- WSJ

17 sept 2024, 21:20 UTC

Principales Noticias

Fed's 'Reverse Repo' Balance Fell to Lowest in Over 3 Years. Why It Matters. -- Barrons.com

17 sept 2024, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

17 sept 2024, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

17 sept 2024, 20:38 UTC

Principales Noticias

The Stock Market Is Priced for Middling Returns No Matter What the Fed Does -- Barrons.com

17 sept 2024, 20:24 UTC

Principales Noticias

U.S. Stocks Pare Gains; Traders Betting on Big Fed Cut -- WSJ

17 sept 2024, 20:05 UTC

Principales Noticias

Meta Extends Ray-Ban Partnership; Zuckerberg Says Glasses 'Next Major Tech Platform' -- IBD

17 sept 2024, 20:00 UTC

Principales Noticias

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- 2nd Update

17 sept 2024, 19:33 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

17 sept 2024, 19:28 UTC

Principales Noticias

U.S. Stocks Give Up Gains; Traders Still Betting on Big Fed Cut -- WSJ

17 sept 2024, 19:10 UTC

Principales Noticias

Forget the Fed. This is the Stock Market's Biggest Risk. -- Barrons.com

17 sept 2024, 19:08 UTC

Charlas de Mercado

Oil Futures Rise on Renewed Middle East Tensions -- Market Talk

17 sept 2024, 18:21 UTC

Charlas de Mercado

Gold Down As Investors Await Fed Decision -- Market Talk

17 sept 2024, 18:06 UTC

Charlas de Mercado

Barrick CEO Argues Valuation Case as Company Targets Growth -- Market Talk

17 sept 2024, 17:36 UTC

Charlas de Mercado

Steel Industry Challenges on Display Amid Warning from Nucor -- Market Talk

17 sept 2024, 17:32 UTC

Charlas de Mercado

Oil Futures Press Higher On Lebanon, Fed Watch -- Market Talk

17 sept 2024, 17:07 UTC

Charlas de Mercado

Canada Housing Construction To Remain Weak Through 2024 -- Market Talk

17 sept 2024, 17:04 UTC

Adquisiciones, fusiones, absorciones

Workday Is Buying Evisort in Move Into AI-Based Document Intelligence -- Barrons.com

17 sept 2024, 17:03 UTC

Principales Noticias

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- Update

17 sept 2024, 16:43 UTC

Charlas de Mercado

Treasury Yields Rise As U.S. Indicators Show Strength -- Market Talk

17 sept 2024, 16:20 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

17 sept 2024, 16:11 UTC

Principales Noticias

JPMorgan in Talks With Apple to Take Over Credit Card From Goldman -- WSJ

17 sept 2024, 16:04 UTC

Principales Noticias

U.S. Stock Indexes Rise; Traders Still Betting on Big Fed Cut -- WSJ

17 sept 2024, 15:57 UTC

Charlas de Mercado

Bank of Canada 'Completely Behind the Curve' -- Market Talk

17 sept 2024, 15:50 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 sept 2024, 15:50 UTC

Charlas de Mercado

Hitting 2% Inflation Not Enough to Justify Faster, Deeper Canada Rate Cuts -- Market Talk

Comparación entre iguales

Cambio de precio

Apellis Pharmaceuticals Inc Esperado

Precio Objetivo

By TipRanks

94.44% repunte

Estimación a 12 meses

Media 70.6 USD  94.44%

Máximo 96 USD

Mínimo 41 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Apellis Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

16 ratings

12

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

59.71 / 72.47Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

104 / 366 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media